Gemcitabine Eugia 40 mg/ml solution à diluer pour perfusion, RILVEGOSTOMIG, Cisplatine Teva 1 mg/ml solution à diluer pour perfusion.
PRODIGE 118-PEHRICCA
Phase 3 small_molecule active
Quick answer
Gemcitabine Eugia 40 mg/ml solution à diluer pour perfusion, RILVEGOSTOMIG, Cisplatine Teva 1 mg/ml solution à diluer pour perfusion. for Hihg risk of cholangiocarcinoma intra hépatic resectable is a Phase 3 program (small_molecule) at CERO THERAPEUTICS HOLDINGS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CERO THERAPEUTICS HOLDINGS, INC.
- Indication
- Hihg risk of cholangiocarcinoma intra hépatic resectable
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active